Covered recipient · General Payments record
MELVA R REVE URGELLES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2022–2024
$813.38
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.95 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.64 | 5 |
| Alkermes, Inc. | $61.58 | 3 |
| Janssen Pharmaceuticals, Inc | $43.70 | 2 |
| Teva Pharmaceuticals USA, Inc. | $25.11 | 1 |
| Indivior Inc. | $25.09 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.95 | 1 |
| ITI, Inc. | $18.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.27 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939480 | CMS |
| ABBVIE INC. | $18.23 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939482 | CMS |
| ABBVIE INC. | $19.49 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939484 | CMS |
| ABBVIE INC. | $19.41 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939486 | CMS |
| ABBVIE INC. | $21.24 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939488 | CMS |
| Alkermes, Inc. | $21.27 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120580169 | CMS |
| Alkermes, Inc. | $21.12 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120580171 | CMS |
| Alkermes, Inc. | $19.19 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120580173 | CMS |
| Indivior Inc. | $25.09 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144536396 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.88 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143305741 | CMS |
| Janssen Pharmaceuticals, Inc | $27.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077983910 | CMS |
| Janssen Pharmaceuticals, Inc | $16.70 | 08/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077983638 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.95 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137661666 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151640633 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.